FDA approves new streamlined workflow option for Roche’s cobas HPV Test – Benzinga

FDA approves new streamlined workflow option for Roche's cobas HPV Test
Benzinga
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, more efficient workflow process for the cobas HPV Test, allowing sample processing from the primary sample collection vial 

and more »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *